These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 25368612)

  • 1. Deception and manipulation: the arms of leishmania, a successful parasite.
    Cecílio P; Pérez-Cabezas B; Santarém N; Maciel J; Rodrigues V; Cordeiro da Silva A
    Front Immunol; 2014; 5():480. PubMed ID: 25368612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective or Detrimental? Understanding the Role of Host Immunity in Leishmaniasis.
    Dos Santos Meira C; Gedamu L
    Microorganisms; 2019 Dec; 7(12):. PubMed ID: 31847221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunopathogenesis of Leishmania infections].
    Yurdakul P
    Mikrobiyol Bul; 2005 Jul; 39(3):363-81. PubMed ID: 16358498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Escaping Deleterious Immune Response in Their Hosts: Lessons from Trypanosomatids.
    Geiger A; Bossard G; Sereno D; Pissarra J; Lemesre JL; Vincendeau P; Holzmuller P
    Front Immunol; 2016; 7():212. PubMed ID: 27303406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shape, form, function and
    Sunter J; Gull K
    Open Biol; 2017 Sep; 7(9):. PubMed ID: 28903998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imaging host-Leishmania interactions: significance in visceral leishmaniasis.
    Forestier CL
    Parasite Immunol; 2013; 35(9-10):256-66. PubMed ID: 23772814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How to master the host immune system? Leishmania parasites have the solutions!
    Rossi M; Fasel N
    Int Immunol; 2018 Mar; 30(3):103-111. PubMed ID: 29294040
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Dialogue of the Host-Parasite Relationship: Leishmania spp. and Trypanosoma cruzi Infection.
    de Morais CG; Castro Lima AK; Terra R; dos Santos RF; Da-Silva SA; Dutra PM
    Biomed Res Int; 2015; 2015():324915. PubMed ID: 26090399
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Efstathiou A; Smirlis D
    Microorganisms; 2021 Mar; 9(4):. PubMed ID: 33801655
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiparasitic chemotherapy: tinkering with the purine salvage pathway.
    Datta AK; Datta R; Sen B
    Adv Exp Med Biol; 2008; 625():116-32. PubMed ID: 18365663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leishmania, the phagosome, and host responses: The journey of a parasite.
    Séguin O; Descoteaux A
    Cell Immunol; 2016 Nov; 309():1-6. PubMed ID: 27531526
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Conceição-Silva F; Morgado FN
    Front Cell Infect Microbiol; 2019; 9():330. PubMed ID: 31608245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes and susceptibility to leishmaniasis.
    Handman E; Elso C; Foote S
    Adv Parasitol; 2005; 59():1-75. PubMed ID: 16182864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Neutrophil Recruitment to the Skin on the Pathology Induced by
    Passelli K; Billion O; Tacchini-Cottier F
    Front Immunol; 2021; 12():649348. PubMed ID: 33732265
    [No Abstract]   [Full Text] [Related]  

  • 15. Interaction of Leishmania with the host macrophage.
    Handman E; Bullen DV
    Trends Parasitol; 2002 Aug; 18(8):332-4. PubMed ID: 12377273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcription Factors Interplay Orchestrates the Immune-Metabolic Response of
    Bichiou H; Bouabid C; Rabhi I; Guizani-Tabbane L
    Front Cell Infect Microbiol; 2021; 11():660415. PubMed ID: 33898331
    [TBL] [Abstract][Full Text] [Related]  

  • 17.
    Martínez-López M; Soto M; Iborra S; Sancho D
    Front Microbiol; 2018; 9():883. PubMed ID: 29867798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular basis of Trypanosoma cruzi and Leishmania interaction with their host(s): exploitation of immune and defense mechanisms by the parasite leading to persistence and chronicity, features reminiscent of immune system evasion strategies in cancer diseases.
    Ouaissi A; Ouaissi M
    Arch Immunol Ther Exp (Warsz); 2005; 53(2):102-14. PubMed ID: 15928579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 24.